Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 385 results for "cipla"

Cipla down 2% on Nomura downgrade, valuations expensive

According to the report, the valuation seems expensive as the brokerage sees limited upside risk to earnings in the near term. Money Control, 5 hours ago

90 images for cipla

Pharma Letter, 3 days ago
Oneindia, 4 days ago
IBNLive India News, 4 days ago
Bio Spectrum Asia, 5 days ago, 4 days ago
4 Traders, 1 week ago
India TV, 1 week ago
Publicity Update, 1 week ago, 1 week ago, 1 week ago

7830 to be Nifty base now; like Cipla, Escorts: Phillip Cap

Vineet Bhatnagar recommends avoiding infrastructure and power space midcap stocks and suggests selling them on any uptick.
 Money Control7 hours ago

Drug makers sign pact with Gilead for cheaper Hepatitis-C drug

Seven India-based drug makers Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific — have signed a licensing agreement with Gilead, a multinational drug company, which allows the generic drug makers to ...
 Business Standard India1 day ago Hepatitis C licence and drug firms  Hindu Business Line1 day ago Gilead Licenses Hepatitis Therapy in India Amid Price Criticism  BusinessWeek1 day ago Indian companies to sign generic licensing deal for Hepatitis C drug Sovaldi [Mint, New Delhi :: ]  BusinessWeek1 day ago

We're not always at loggerheads with innovator companies: Denis Broun

w with Global Director for Access and Public Affairs, Cipla Global Sushmi Dey | New Delhi September 16, 2014 Last Updated at 00:37 IST Related News We're not always at loggerheads with innovator companies: Denis Broun Mumbai-headquartered Cipla Global, known ...
 Business Standard1 day ago
Bio Spectrum Asia

Cipla enters Czech & Slovakian markets

Singapore: Under the collaboration, Cipla will be driving its respiratory product portfolio in both Czech Republic and Slovakia through a Cipla owned sales force team, managed by Cipla commercial head. Mr Frank Pieters, head, Cipla Europe said, ...
 Bio Spectrum Asia6 days ago Cipla and S&D Pharma partner for business in Czech Republic and Slovakia  Pharmaceutical Technology6 days ago Cipla collaborates with S&D Pharma  Express Pharma1 week ago Cipla partners with S&D Pharma to tap Czech Republic and Slovakia  Business Standard1 week ago
Business Standard

Cipla at new high, eyes deal with Gilead for hepatitis drug

US-based drug maker Gilead Sciences may join hands with atleast five Indian generic pharmaceutical companies for manufacturing and selling cheaper versions of its new hepatitis C medicines.
 Money Control2 days ago Cipla hits new high; stock gains 10% in two days  Business Standard2 days ago Gilead's deal with Indian generic drug companies will help earn goodwill for the industry  The Hindu19 hours ago Gilead hands Sovaldi manufacturing tech to 7 generics makers  FiercePharmaManufacturing1 day ago

Cipla, Dr Reddy’s spurt up on BSE

Cipla was up 2.92 per cent at ₹630.45 as against its previous close at ₹612.55
 MSN India2 days ago Cipla vaults over 6% on BSE  Hindu Business Line5 days ago Cipla surges 1.7% on BSE  Hindu Business Line1 week ago

Lupin, Cipla lead the pack on NSE

Pharma stocks Lupin and Cipla led the pack on the NSE near the close on Monday. At 3.35 pm Lupin was the top gainer, quoting at ₹1,415.90 as against ₹1,359 at close last week. This represented a gain of 4.19 per cent. Cipla was quoting at ...
 Hindu Business Line2 days ago Pharma stocks lead the pack on NSE  Hindu Business Line5 days ago Cipla leads the pack on NSE, up 1.46% in morning session  INooz1 week ago IT stocks lead among gainers  Equitymaster.com4 hours ago

Top buzzing stocks of Sep 15

Here are the top buzzing stocks of Sep 15 -Fortis healthcare, Mastek, Nitesh Estates, Just dial, Cipla.
 Money Control2 days ago Here are top buzzing stocks to watch on Sep 2  Money Control2 weeks ago

Cipla holds firm, keeps gains of 2.6% on BSE

Pharma stock Cipla and Dr Reddy's Labs began the week on a firm note. At 11.10 am the two shares were the top gainers on the BSE. Cipla was up 2.92 per cent at ₹630.45 as against its previous close at ₹612.55. Dr Reddy's Labs gained 0.88 per ...
 Hindu Business Line2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less